Biopharmaceutical leader in the development of treatments for rare diseases
Education with respect to the transparency of biopharmaceutical pricing in France. H.R. 1416: Cancer Patient Protection Act of 2013.

Monitored legislative efforts to reform the Sustainable Growth Rate (SGR) formula for physicians in Medicare. H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013.
S. 957: Drug Supply Chain Security Act.
S. 959: Pharmaceutical Compounding Quality and Accountability Act.
H.R. 3089: Compounding Clarity Act of 2013.H.R. 3024: The Drug Quality and Security Act.
TRD - Trade (domestic/foreign) MMM - Medicare/Medicaid HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
W STRATEGIES, LLC
1455 Pennsylvania Avenue, NW, Suite 400, Washington, DC, 20004, US
DARREN WILLCOX DARREN WILLCOX DARREN WILLCOX